Terran Biosciences' founder and CEO Sam Clark talks about big opportunities for prodrug development in 2025, the importance of a strong medicinal chemistry team, and a potential increase in M&A ...

The pharmaceutical industry sits on a treasure trove of data, brimming with the potential to revolutionize drug development, enhance patient care, and optimize commercial strategies. Yet, this vast ...

The life sciences industry contributed nearly $4 billion to the U.S. economy in 2021 and is expected to continue growing an average 7% to 8% per year over the next five years. With an increasing ...

Inozyme's CEO and chairman Douglas Treco shares his thoughts about the rousing success of the Orphan Drug Act, but cautions rare disease drug developers against sky high and inaccessible drug pricing ...

Life Science Leader is an essential business publication for life science executives who work at everything from emerging biotechs to large pharmaceutical companies. Our content is designed to inform ...

In the downstream processes of mAb purification, mAb purity is high following the capture step. For this reason, it is crucial to remove impurities left after the capture step. To improve the purity ...

Life Biosciences' Jerry McLaughlin and Forge Biologics' John Maslowski explain the importance of transparency and collaboration when encountering manufacturing speed bumps.

Rahul Kakkar was the director for emerging innovations, scientific partnering, and alliances before founding Tome Biosciences and explains his move from Big Pharma to small bio.

NCBiotech and their coalition of partners received a $25 million Phase 2 award from the U.S. Economic Development Administration’s Build Back Better Regional Challenge. This award will further ...

In this Business Solutions podcast, John Bodrozic, cofounder of software developer HomeZada, discusses some of the challenges software developer companies face when raising capital. While bootstrap ...

How is the state of the industry being affected by government policies, talent pools, and supply chain constraints? Hear from Dave Tudor, Managing Director of Pharma, HealthTech, and Quality at CPI, a ...

With the European Union's Medical Devices Regulation now in full effect, manufacturers face the imperative task of comprehending and adhering to its stipulations. Manufacturers must ascertain their ...